Recent Insider Transactions
| 12/34/56 |
MoonLake Immunotherapeutics
Chief Executive Officer
|
S |
Class A ordinary shares, par value $0.0001 per share |
$0.00 |
0.00 |
$0 |
|
| 12/34/56 |
MoonLake Immunotherapeutics
Chief Executive Officer
|
A |
Stock Option (Right to Buy) |
$0.00 |
0.00 |
$0 |
|
| 12/34/56 |
MoonLake Immunotherapeutics
Chief Executive Officer
|
C |
Class A ordinary shares, par value $0.0001 per share |
$0.00 |
0.00 |
$0 |
|
| 12/34/56 |
MoonLake Immunotherapeutics
Chief Executive Officer
|
C |
Common shares, par value CHF 0.10 per share, of MoonLake AG |
$0.00 |
0.00 |
$0 |
|
| 12/34/56 |
MoonLake Immunotherapeutics
Chief Executive Officer
|
D |
Class C ordinary shares, par value $0.0001 per share |
$0.00 |
0.00 |
$0 |
|